These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Furukawa Y; Matsumori A; Hirozane T; Sasayama S Circulation; 1996 Jan; 93(2):333-9. PubMed ID: 8548907 [TBL] [Abstract][Full Text] [Related]
5. Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA. Zhang QW; Tomita Y; Matsuzaki G; Uchida T; Yoshikawa M; Nakashima Y; Sueishi K; Nomoto K; Yasui H Transpl Int; 2001 Jun; 14(3):143-52. PubMed ID: 11499903 [TBL] [Abstract][Full Text] [Related]
6. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells. Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791 [TBL] [Abstract][Full Text] [Related]
7. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts. Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337 [TBL] [Abstract][Full Text] [Related]
8. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Orosz CG; Wakely E; Bergese SD; VanBuskirk AM; Ferguson RM; Mullet D; Apseloff G; Gerber N Transplantation; 1996 Mar; 61(5):783-91. PubMed ID: 8607184 [TBL] [Abstract][Full Text] [Related]
9. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Koskinen PK; Lemström KB; Häyry PJ Am J Pathol; 1995 Apr; 146(4):972-80. PubMed ID: 7536397 [TBL] [Abstract][Full Text] [Related]
10. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy. Soleimani B; Fu F; Lake P; Shi VC J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883 [TBL] [Abstract][Full Text] [Related]
11. Local cellular immunology of experimental transplant vascular sclerosis. Orosz CG Clin Transplant; 1996 Feb; 10(1 Pt 2):100-3. PubMed ID: 8680044 [TBL] [Abstract][Full Text] [Related]